The primary cilium acts as a transducer of extracellular stimuli into intracellular signaling [1, 2] . Its regulation, particularly with respect to length, has been defined primarily by genetic experiments and human disease states in which molecular components that are necessary for its proper construction have been mutated or deleted [1] . However, dynamic modulation of cilium length, a phenomenon observed in ciliated protists [3, 4] , has not been wellcharacterized in vertebrates. Here we demonstrate that decreased intracellular calcium (Ca 2+ ) or increased cyclic AMP (cAMP), and subsequent protein kinase A activation, increases primary cilium length in mammalian epithelial and mesenchymal cells. Anterograde intraflagellar transport is sped up in lengthened cilia, potentially increasing delivery flux of cilium components. The cilium length response creates a negative feedback loop whereby fluid shear-mediated deflection of the primary cilium, which decreases intracellular cAMP, leads to cilium shortening and thus decreases mechanotransductive signaling. This adaptive response is blocked when the autosomal-dominant polycystic kidney disease (ADPKD) gene products, polycystin-1 or -2, are reduced. Dynamic regulation of cilium length is thus intertwined with cilium-mediated signaling and provides a natural braking mechanism in response to external stimuli that may be compromised in PKD.
Summary
The primary cilium acts as a transducer of extracellular stimuli into intracellular signaling [1, 2] . Its regulation, particularly with respect to length, has been defined primarily by genetic experiments and human disease states in which molecular components that are necessary for its proper construction have been mutated or deleted [1] . However, dynamic modulation of cilium length, a phenomenon observed in ciliated protists [3, 4] , has not been wellcharacterized in vertebrates. Here we demonstrate that decreased intracellular calcium (Ca 2+ ) or increased cyclic AMP (cAMP), and subsequent protein kinase A activation, increases primary cilium length in mammalian epithelial and mesenchymal cells. Anterograde intraflagellar transport is sped up in lengthened cilia, potentially increasing delivery flux of cilium components. The cilium length response creates a negative feedback loop whereby fluid shear-mediated deflection of the primary cilium, which decreases intracellular cAMP, leads to cilium shortening and thus decreases mechanotransductive signaling. This adaptive response is blocked when the autosomal-dominant polycystic kidney disease (ADPKD) gene products, polycystin-1 or -2, are reduced. Dynamic regulation of cilium length is thus intertwined with cilium-mediated signaling and provides a natural braking mechanism in response to external stimuli that may be compromised in PKD.
Results and Discussion
To test the potential role of known signaling pathways in governing cilium length, we carried out a small-scale screen of bioactive compounds with known targets to test their ability to acutely increase cilium length (i.e., within 3 hr). Our screen utilized the immortalized kidney collecting duct line (IMCD) [5] , embryonically derived kidney epithelia (MEK) [6] , and primary bone mesenchymal cells (BME) [7] . These cells were chosen for their robust formation of primary cilia upon reaching confluence in cell culture, as observed by indirect immunofluorescence microscopy ( Figure 1A ; see also Figures S1A and S1C available online). Two major classes of compounds emerged as potent stimulators of cilium length in all three cell types: molecules directed at blocking Ca 2+ entry into cells or release of intracellular Ca 2+ stores (e.g., Gd 3+ ) and those increasing intracellular cyclic AMP (cAMP) (e.g., forskolin [8] ). These compounds increased cilium length almost 2-fold in 3 hr ( Figures 1A and 1B) . In IMCD cells, cilia length increased from 6.0 6 0.4 to 10.7 6 1.75 and 11.7 6 1.1 mm (mean 6 standard deviation) after Gd 3+ and forskolin treatment, respectively. Similar results were seen in both MEK and BME cells ( Figure 1C ; Figures S1B and S1D) .
Using a number of compounds that modulate levels of intracellular second messengers, we were able to further explore the effect of Ca 2+ and cAMP on cilium length ( Figure 2A ). The ryanodine receptor inhibitor dantrolene, which acts to prevent Ca 2+ release, increased cilium length. In contrast, releasing intracellular calcium stores (e.g., thapsigargin) or activation of polycystin-2, a Ca 2+ -permeable, nonselective cation channel, via triptolide [9] modestly decreased cilium length. Use of a cAMP analog, 8-Br-cAMP, which directly activates protein kinase A/cAMP-dependent kinase (PKA) also increased cilium length. Conversely, a competitive inhibitor of PKA activation Rp-cAMPS or direct inhibition of PKA by H-89 or KT5720 resulted in shortening of the cilium (Figure 2A) . Thus, increasing intracellular cAMP and subsequent downstream activation of PKA acted to increase cilium length, and inhibition of PKA activity reduced cilium length and the converse observed for intracellular Ca 2+ . Inhibition of phosphodiesterase activity had no significant effect on cilium length ( Figure S2A ), indicating that a constitutive cAMP degradation activity is not acting in these cells over the time course of our experiment. Compounds targeting cyclic guanosine nucleotide (cGMP)-mediated pathways did not affect mammalian primary cilium length ( Figure S2B ), in contrast to its effect on the morphology of nematode sensory cilia [10] .
The increase in cilium length did not require protein synthesis because each drug was effective in the presence of cycloheximide, a protein synthesis inhibitor ( Figure S2C ). In addition, the length increase was reversed either by removal of the drug after treatment (data not shown) or by chelation of Gd 3+ by addition of a stoichiometric concentration of ethylene glycol tetraacetic acid (EGTA, 30 mM, much less than required for Ca 2+ chelation) after the initial length increase ( Figure S2D ). To ascertain potential crosstalk between the signaling pathways, we measured the levels of second messengers directly after administration of the two most potent compounds, forskolin and Gd 3+ . Measurements of steady-state intracellular cAMP levels were increased 2-fold by Gd 3+ and 6-fold by forskolin in comparison to untreated cells ( Figure 2B ). Steady-state intracellular Ca 2+ levels were reduced 43% and 37% when cells were treated with Gd 3+ and forskolin, respectively ( Figure 2C ). Together, these data reveal the crosstalk between Ca 2+ and cAMP and suggest that their coordinate regulation modulates cilium length and that they may converge on a common final effector.
Titration of the forskolin response with a specific PKA inhibitor prevented cilium lengthening, indicating that PKA is the downstream element in the cAMP-mediated cilium length *Correspondence: jagesh_shah@hms.harvard.edu regulation ( Figure 2D ; Figure S2E ). PKA inhibition also prevented Gd
3+
-induced cilium length increase. Conversely, thapsigargin suppressed the effect of forskolin cilium lengthening but had no effect on 8-Br-cAMP-induced cilium lengthening (10.96 6 1.09 and 9.32 6 1.59 mm under 8-Br-cAMP and 8-Br-cAMP plus thapsigargin incubation, respectively; Figure 2D; Figure S2F ), indicating a potential role for Ca 2+ modulation of adenylyl cyclases (AC). To investigate the role of AC in this pathway, we used short interfering RNAs to knock down the expression of AC5 and AC6, two isoforms found in our cell lines and inhibited by Ca 2+ [11] ( Figures S2G and S2H ). The siRNA-mediated knockdown of AC5 or AC6 blocked cilium lengthening via Gd 3+ (i.e., acting via Ca 2+ ) but not via 8-Br-cAMP (i.e., direct PKA activation) ( Figure 2E ; Figure S2I ). These data are consistent with a signaling pathway in which PKA activation, either directly via 8-Br-cAMP or indirectly via AC activation, increases cilium length. This pathway is active in cells of epithelial and mesenchymal origin, underscoring a generalized control of primary cilium length in many tissues.
To investigate mechanisms by which PKA may regulate cilium length, we observed the delivery of constituent proteins to the cilium by imaging the intraflagellar transport (IFT) machinery [12] . IFT particles are transported along axonemal microtubules toward the cilium tip (anterograde) and removed by transport toward the cell body (retrograde). Cilium length regulation requires coordinate regulation of particle trafficking, size, frequency, and speed to modulate the particle flux [3] . We visualized IFT particle trafficking by labeling an IFT component, IFT88, with enhanced yellow fluorescent protein (EYFP) (Figures 3A and 3B; Movies S1-S3) [13] . Upon addition of compounds to increase cilium length, anterograde IFT88 particle velocities increased by w70%. In contrast, there were no significant effects on retrograde velocities ( Figures 3C-3E) . Moreover, the lengthened cilia displayed greater fluorescence at the tip, indicating accumulation of IFT88 consistent with an increased anterograde and unchanged retrograde velocities ( Figure 3B ). This increase in anterograde velocity of transport, without a significant change in retrograde velocity, could result in an increase in material flux into the cilium, thereby leading to increased length. However, the material flux is derived from a number of parameters such as particle number, size, and occupancy that we have not measured here, requiring a more detailed analysis to understand the contribution of increased anterograde velocity to the length increase. The dynamic modulation of particle velocity has not previously been reported in mammalian cells (for Chlamydomonas, see [14] ) and represents a novel form of control for cargo transport. One possible mechanism at work can be inferred from studies of the nematode cilium where two motors, kinesin-II and OSM3, both contribute to IFT but move at different velocities [15] . Ablation of kinesin-II, the slower motor (and in a mutant Bardet-Biedl syndrome (bbs) background), results in all IFT particles moving at the faster OSM3 velocity, and the ablation of OSM3 (again in a bbs mutant background) results in all IFT particles moving at the slower kinesin-II velocity. A mechanism to dynamically titrate motor stoichiometries on IFT particles could be used to regulate particle velocity. In addition to motor-IFT composition, there may also exist some enzymatic modulation of the motor itself or modification of the microtubule track [16] that may impact IFT transport. Recent work from Engel and colleagues [14] demonstrates that motor velocity changes as a function of length in regenerating Chlamydomonas flagella after pH shock. Their work suggests that flagellar length may itself be upstream of motor velocity control rather than downstream. Further study will be required to identify the underlying mechanisms of increased anterograde IFT particle velocity.
The dynamic control of cilium length that we have observed could provide a unique regulatory mechanism for the control of sensitivity to extracellular cues. Given the similarity in coregulation of intracellular Ca 2+ and cyclic AMP between cilium length control and flow mechanotransductive signaling [17, 18] , we tested the effect of flow on cilium length. Primary cilia in a number of tissues, most notably the kidney tubule and hepatobiliary tree, transduce low-shear-stress fluid flow via cilium deflection and Ca 2+ influx [19] . After exposing kidneyderived IMCD and MEK epithelial cells to 3 hr of shear stress (0.75 dyne/cm 2 ), we found that both untreated cells and forskolin-treated cells had shorter cilia (20%-35%, p < 0.05) ( Figure 4A ). Intracellular cyclic AMP levels were also significantly decreased (1.5-to 3-fold) under flow, even in the presence of forskolin (as previously described by Masyuk and colleagues [18] ), and are consistent with the observed cilium length reduction ( Figure 4C ). Similar results were also observed in wild-type MEK cells (Figures 4B and 4D ). The effect of cilium length reduction would reduce the length of the lever arm and decrease the sensitivity to fluid shear stress, creating a previously unappreciated negative feedback loop to adapt intracellular signaling to external cues.
Interestingly, Gd 3+ treatment blocked the cilium length decrease under flow and the reduction in cyclic AMP levels ( Figures 4C and 4D) . The action of Gd 3+ is rather promiscuous; however, it has been shown to block the activity of polycystin-2 (PC2), a transient receptor potential channel involved in Ca 2+ entry under flow-mediated shear stress [20] . We investigated the role of PC2 and its binding partner polycystin-1 (PC1) as regulators of cilium length because both are known to regulate flow mechanotransduction and are mutated in autosomaldominant forms of polycystic kidney disease (ADPKD) [21] . IMCD cells stably knocked down for PC2 (to w20% of wildtype levels; Figure S3A ) were subjected to flow but did not exhibit the cilium length decrease as seen in their parental counterparts under untreated conditions or forskolin addition ( Figure 4E ). As expected from the lack of cilium length modulation, these cells were unable to decrease cAMP levels under flow ( Figure 4G ). Moreover, these cells exhibited a hyperactive cAMP response to forskolin (w2.5-fold over wild-type cells) that was maintained in the presence of flow. We tested the role of PC1 via MEK cell lines generated from mice with a mutation (del34) in the gene encoding for PC1 [6] (Figure S3B ). Like the PC2 knockdown cells, these cells did not exhibit cilium shortening or a decrease in intracellular cyclic AMP under flow, indicating a role for polycystins in cilium length adaptation ( Figures 4F and 4H) . Notably, cells mutated for PC1 or knocked down for PC2 all responded to forskolin in a similar fashion to wild-type cells, with respect to cilium length, under static conditions but did not undergo cilium length increase upon administration of Gd
. The response of wild-type cells to Gd 3+ might be expected to act like knockdown of PC1 and/or PC2, given the reduced Ca 2+ level ( Figures S3E and  S3F ). However, there was no difference in untreated cilium lengths for wild-type cells or cells with reduced PC1 and/or PC2 function (Figures 4A and 4E ). This suggests that cells can adapt cilium length via an as-yet-unidentified mechanism under chronic conditions (e.g., mutation or long-term knockdown) but that acute perturbations of Ca 2+ homeostasis (e.g., via Gd 3+ administration) modulate cilium length via the activity of PC1 and/or PC2.
Dynamic cilium length regulation has been observed in a number of unicellular ciliates, for example in Chlamydomonas after deflagellation [4, 22] . However, the dramatic and reversible cilium length increase seen here has not been previously studied in mammalian cells and even remains poorly understood in unicellular ciliated organisms. The data presented here demonstrate that modulation of intracellular Ca 2+ and cyclic AMP and its downstream activation of PKA controls cilium length in part by regulating IFT particle transport velocity and possibly material anterograde flux. This second-messenger-mediated control regulates cilium length downstream of cellular signals such as flow-induced mechanotransduction, reducing sensitivity to fluid shear by decreasing cilium length. The ADPKD proteins PC1 and PC2 regulate this adaptation, and in their absence, cells are 3+ or forskolin treatment resulted in cilium length reduction (*p < 0.05). Increasing intracellular calcium (thapsigargin) suppressed the effect of direct adenylyl cyclase activation (forskolin) on cilium length but had no effect on the cilia lengthening caused by the direct activation of PKA (8-Br-cAMP). **p < 0.001. (E) Silencing of AC5 or AC6 prevented cilium lengthening in response to Gd 3+ but not PKA activation by 8-Br-cAMP. The bar graph represents the average length of cilia after 48 hr of small interfering RNA (siRNA)-mediated knockdown, followed by 3 hr of drug treatment. GAPDH siRNA was used as a control for siRNA targeting. n = 100 (*p < 0.001, **p < 0.05). Error bars indicate mean 6 SD.
unable to downregulate cAMP; thus, cilium length remains unchanged.
This novel form of mechanical adaptation acts to modulate the response to fluid shear and potentially other extracellular cues. Polycystins act as a brake on signaling. In their absence, signaling would continue unabated. The regulation of signaling by flow-induced mechanotransduction has been widely hypothesized as a mechanism that may be defective in PKD Error bars indicate mean 6 SD. *p < 0.05, **p < 0.001. [23] . Careful studies from Verghese and colleagues indicate that renal tubular cilia length is modulated during various forms of renal injury and repair ( [24, 25] and our own unpublished data), implicating dynamic length regulation as part of a regenerative program. Given that these injury models themselves can act to potentiate cystogenesis in mouse models of PKD [26] [27] [28] , it is appealing to speculate that dynamic cilium length regulation may be a part of an anticystogenic repair program that, when absent, contributes to cystic pathology.
Experimental Procedures
Live-Cell Imaging of Intraflagellar Transport Velocity measurements of IFT particles were performed as described previously [13] . Briefly, m368-4 cells (clonal line of IMCD cells stably expressing IFT88-EYFP) were cultured on 18 mm poly-L-lysine-coated coverslips in Dulbecco's modified Eagle's medium/10% fetal bovine serum. A confluent monolayer of cells was subjected to IFT transport analysis by inversion onto a large coverslip and a drop of CO 2 -independent media (Invitrogen) and was imaged by high numerical aperture fluorescence microscopy on a TE2000 E2 inverted microscope system (Nikon) heated with an enclosed chamber (In Vivo Scientific). Time-lapse images were captured by IPLab software to a cooled charge-coupled device camera (CoolSNAP HQ, Roper Scientific). Images were collected at 500-750 ms intervals with a PlanApo 603 NA 1.4 oil objective with exposure 200-500 ms at 2 3 2 binning. To determine the IFT particles' velocities, we assembled time-lapse image sequences into kymographs with the ImageJ software package (http:// rsbweb.nih.gov/ij). IFT velocities were analyzed in control cells and cells pretreated for 3 hr with the appropriate compound.
Cyclic AMP Measurements
Confluent murine IMCD and MEK cells were lysed in 0.1 M HCl. Lysed samples were incubated at room temperature for 20 min. Samples were then transferred to the centrifuge tubes and spun at maximum speed in a tabletop microcentrifuge for 10 min. The supernatants were analyzed for cAMP via a direct immunoassay kit (BioVision). The results were expressed as pmol of cAMP per mg of protein. The protein concentration was determined by using Bradford protein assay kit (Pierce).
Statistical Analysis
Cilia length, IFT velocities, cAMP, and calcium measurements were analyzed via one-way analysis ANOVA with OriginPro 7.5 (OriginLab). All results were expressed as mean 6 standard deviation (data from R3 independent experiments). Results were considered significant at p < 0.05.
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